EUVIMEDEUVIMED entdecken
Crossref

HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation

Chien-Ming Chiang, Yih-Jyh Lin, Wen-Chun Liu, Tsung-Ching Chou, Chih-Hsuan Tsai, Ting-Tsung Chang, I-Chin Wu iD

Journal of Medical Virology · 2025

DOI: 10.1002/jmv.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Chien-Ming Chiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan. Hauptthemen laut MEDLINE: Liver Transplantation, Hepatitis B, Chronic, Hepatitis B virus, Immune Evasion. Die Arbeit nennt 40 Literaturangaben. Gefördert von: This study was supported by grants from the National Cheng Kung University (NCKUH-10604007, NCKUH-10902005, NCKUH-11102011, and NCKUH-11202022)., National Cheng Kung University Hospital.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The posttransplantation recurrence rate of hepatitis B virus (HBV) infection in patients with chronic hepatitis B (CHB) is underestimated and linked with unfavorable outcomes. We investigated HBV recurrence by serum assays in patients with CHB following liver transplantation. We enrolled patients with CHB who underwent liver transplantation between March 2001 and July 2021 to participate in cross‐sectional testing for HBV‐related serum markers, including biochemical analysis for HBsAg and hepatitis B core‐related antigen (HBcrAg) and real‐time RT‐PCR/PCR for HBV RNA and HBV DNA, in 2022. HBV recurrence in this study was defined as positive results of at least one posttransplantation HBV‐related serum markers. Next‐generation sequencing was performed for those with posttransplantation virological breakthroughs. Ninety‐six patients with CHB who underwent liver transplantation were enrolled. Among 84 patients who received grafts negative for HBsAg, 41 (48.8%) exhibited HBV recurrence, and they tested positive for either HBsAg or HBcrAg, or both. High‐risk patients, identified using a risk stratification model, had a higher likelihood of recurrence than low‐risk patients (odds ratio: 2.59, 95% confidence interval: 1.06–6.35, p = 0.038). In 51 patients who tested negative for HBsAg after receiving HBsAg‐negative grafts, 8 (15.7%) had positive HBcrAg, indicating occult HBV infection (OBI). We identified immune escape mutations and altered N‐glycosylation patterns on the surface protein in patients experiencing virological breakthroughs following lamivudine resistance. HBsAg plus HBcrAg levels can be used to detect posttransplantation HBV recurrence. The OBI prevalence was higher in patients transplanted with HBsAg‐negative liver grafts compared to blood donors, vaccinated young population, and community‐based populations reported in literatures, possibly because of immune escape mutations or altered N‐glycosylation patterns of surface proteins.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationHepatitis B, ChronicHepatitis B virusImmune EvasionHumansMaleFemaleMiddle AgedHepatitis B Surface AntigensAdultRecurrenceCross-Sectional StudiesDNA, ViralHepatitis B Core AntigensMutationBiomarkersAgedAntiviral AgentsRNA, Viral

Stichwörter der Autor:innen

hepatitis B core‐related antigenimmune escapeliver transplantationoccult hepatitis B virus infection

Substanzen

Hepatitis B Surface AntigensDNA, ViralHepatitis B Core AntigensBiomarkersAntiviral AgentsRNA, Viral

Autor:innen und Institutionen

  • Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Department of Nursing, National Tainan Junior College of Nursing, Tainan, Taiwan.
  • Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
  • Medical Department, Ministry of Health and Welfare Hengchun Tourism Hospital, Pingtung, Taiwan.

ORCID-Profile: I-Chin Wu

Förderung

  • This study was supported by grants from the National Cheng Kung University (NCKUH-10604007, NCKUH-10902005, NCKUH-11102011, and NCKUH-11202022).
  • National Cheng Kung University Hospital

Zitieren

APA

Chiang, C. M., Lin, Y. J., Liu, W. C., Chou, T. C., Tsai, C. H., Chang, T. T., & Wu, I. C. (2025). HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation. Journal of Medical Virology. https://doi.org/10.1002/jmv.70306

Vancouver

Chiang CM, Lin YJ, Liu WC, Chou TC, Tsai CH, Chang TT, et al. HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation. Journal of Medical Virology. 2025. doi:10.1002/jmv.70306

BibTeX
@article{Chiang2025,
  author = {Chiang, Chien-Ming and Lin, Yih-Jyh and Liu, Wen-Chun and Chou, Tsung-Ching and Tsai, Chih-Hsuan and Chang, Ting-Tsung and Wu, I-Chin},
  title = {HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation},
  journal = {Journal of Medical Virology},
  year = {2025},
  doi = {10.1002/jmv.70306}
}
Kostenlos starten →